Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""STAT3"" wg kryterium: Temat


Tytuł:
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.
Autorzy:
Hu Y; Tianjian Laboratory for Advanced Biomedical Sciences, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.; Medical Research Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450052, Henan, China.
Dong Z; Tianjian Laboratory for Advanced Biomedical Sciences, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China. .; China-US (Henan) Hormel Cancer Institute, Zhengzhou, 450008, Henan, China. .; Cancer Chemoprevention International Collaboration Laboratory, Zhengzhou, Henan, China. .
Liu K; Tianjian Laboratory for Advanced Biomedical Sciences, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China. .; China-US (Henan) Hormel Cancer Institute, Zhengzhou, 450008, Henan, China. .; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou, Henan, China. .; Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou, Henan, China. .; Cancer Chemoprevention International Collaboration Laboratory, Zhengzhou, Henan, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jan 20; Vol. 43 (1), pp. 23. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
STAT3 Transcription Factor*/genetics
STAT3 Transcription Factor*/metabolism
Neoplasms*/drug therapy
Neoplasms*/genetics
Neoplasms*/pathology
Humans ; Signal Transduction ; Immunosuppression Therapy ; Drug Discovery ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies.
Autorzy:
Khan F; Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 602105, India.
Pandey P; University Centre for Research and Development, Chandigarh University, Gharuan, Mohali 140413, India.
Verma M; University Centre for Research and Development, Chandigarh University, Gharuan, Mohali 140413, India.; Department of Chemistry, University Institute of Sciences, Chandigarh University, Gharuan, Mohali 140413, India.
Upadhyay TK; Department of Biotechnology, Parul Institute of Applied Sciences and Research and Development Cell, Parul University, Vadodara 391760, India.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 07; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms*/drug therapy
STAT3 Transcription Factor*/metabolism
Humans ; Apoptosis ; Cell Proliferation ; Plant Extracts/pharmacology ; Signal Transduction ; Terpenes/pharmacology
Czasopismo naukowe
Tytuł:
Anti-inflammatory effects of reticuline on the JAK2/STAT3/SOCS3 and p38 MAPK/NF-κB signaling pathway in a mouse model of obesity-associated asthma.
Autorzy:
Lyu X; Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Liu J; Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Liu Z; Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Wu Y; Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Zhu P; Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Liu C; Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2024 Jan; Vol. 18 (1), pp. e13729.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma*/drug therapy
Asthma*/metabolism
Benzylisoquinolines*/pharmacology
Benzylisoquinolines*/therapeutic use
Janus Kinase 2*/drug effects
Janus Kinase 2*/metabolism
NF-kappa B*/drug effects
NF-kappa B*/metabolism
STAT3 Transcription Factor*/drug effects
STAT3 Transcription Factor*/metabolism
Animals ; Mice ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Bronchoalveolar Lavage Fluid ; Cytokines/metabolism ; Disease Models, Animal ; Inflammation/metabolism ; Lung/pathology ; Mice, Inbred BALB C ; Obesity/complications ; Obesity/drug therapy ; p38 Mitogen-Activated Protein Kinases/metabolism ; p38 Mitogen-Activated Protein Kinases/pharmacology ; p38 Mitogen-Activated Protein Kinases/therapeutic use ; Signal Transduction ; Suppressor of Cytokine Signaling 3 Protein/drug effects ; Suppressor of Cytokine Signaling 3 Protein/metabolism
Czasopismo naukowe
Tytuł:
ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
Autorzy:
Li YK; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Gao AB; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.; Clinical Research Institute, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zeng T; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Liu D; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Zhang QF; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Ran XM; Department of Gynecologic Oncology, School of Medicine, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya, Central South University, Changsha, Hunan, China.
Tang ZZ; Department of Gynecologic Oncology, School of Medicine, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya, Central South University, Changsha, Hunan, China.
Li Y; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Liu J; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zhang T; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Shi GQ; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zhou WC; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zou WD; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Peng J; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Zhang J; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. .
Li H; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. lihui_.
Zou J; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. .; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Jan 11; Vol. 22 (1), pp. 46. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Cystadenocarcinoma, Serous*
Ovarian Neoplasms*/genetics
STAT3 Transcription Factor*
Janus Kinase 2*
Animals ; Female ; Humans ; Tumor Microenvironment ; Molecular Docking Simulation ; Angiogenesis ; Zebrafish/metabolism ; Carcinogenesis ; Cell Proliferation ; Carcinoma, Ovarian Epithelial ; Cell Line, Tumor ; Angiopoietin-Like Protein 4/genetics ; Neoplasm Proteins ; Proteoglycans
Czasopismo naukowe
Tytuł:
STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma.
Autorzy:
Wang L; Department of Obstetrics and Gynecology, Center of Genetics and Prenatal Diagnosis, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China.
Zhao QF; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, P. R. China.; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, P. R. China.
Yang BB; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, P. R. China.; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, P. R. China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, P. R. China.
Liang HJ; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, P. R. China.; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, P. R. China.
Zhang XE; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, P. R. China.; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, P. R. China.; Second People's Hospital of Henan Province, Zhengzhou, P. R. China.
Zhang XY; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, P. R. China.; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, P. R. China.
Yang WJ; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, P. R. China.; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, P. R. China.
Guo ZY; SanQuan College of XinXiang Medical University, Xinxiang, P. R. China.
Xu X; College of Biotechnology, Center for Self-Propelled Nanotechnologies, Suzhou Industrial Park Institute of Services Outsourcing, Suzhou, P. R. China.; Translational Cancer Research Laboratory, Suzhou Acumen Medical Technology, Suzhou, P. R. China.
Tian F; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, P. R. China.; Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, P. R. China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, P. R. China.
Wu QH; Department of Obstetrics and Gynecology, Center of Genetics and Prenatal Diagnosis, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1757-1766. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/pathology
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/pathology
STAT3 Transcription Factor*/genetics
STAT3 Transcription Factor*/metabolism
Receptor, EphA7*/metabolism
Humans ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Signal Transduction
Czasopismo naukowe
Tytuł:
Contribution of Signal Transducer and Activator of Transcription 3 (STAT3) to Bone Development and Repair.
Autorzy:
Sobah ML; School of Medicine, Deakin University, Waurn Ponds, Geelong, VIC 3216, Australia.
Liongue C; Institute of Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Waurn Ponds, Geelong, VIC 3216, Australia.
Ward AC; Institute of Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Waurn Ponds, Geelong, VIC 3216, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 27; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
STAT3 Transcription Factor*/genetics
Zebrafish*/genetics
Animals ; Humans ; Bone Development/genetics ; Chondrogenesis ; Osteogenesis/genetics
Czasopismo naukowe
Tytuł:
Endothelial Stat3 activation promotes osteoarthritis development.
Autorzy:
Li J; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.; School of Medicine, Shanghai University, Shanghai, China.; School of Life Sciences, Shanghai University, Shanghai, China.
Zhang W; Department of Orthopedics, First Affiliated Hospital, Jinan University, Guangzhou, China.
Liu X; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.
Li G; Department of Orthopedics, Shanghai Zhongye Hospital, Shanghai, China.
Gu Y; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.; School of Medicine, Shanghai University, Shanghai, China.
Zhang K; Department of Orthopedics, Honghui Hospital, Xi'an Jiao Tong University, Xi'an, China.
Shen F; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.; School of Medicine, Shanghai University, Shanghai, China.
Wu X; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.; School of Medicine, Shanghai University, Shanghai, China.
Jiang Y; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.
Zhang Q; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.
Zhou F; Department of Orthopedics, Honghui Hospital, Xi'an Jiao Tong University, Xi'an, China.
Xu K; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.; Wenzhou Institute of Shanghai University, Wenzhou, China.
Su J; Institute of Translational Medicine, Shanghai University, Shanghai, China.; Organoid Research Center, Shanghai University, Shanghai, China.; Department of Orthopaedics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Cell proliferation [Cell Prolif] 2023 Dec; Vol. 56 (12), pp. e13518. Date of Electronic Publication: 2023 Jun 13.
Typ publikacji:
Journal Article
MeSH Terms:
Cartilage, Articular*/metabolism
Osteoarthritis*/metabolism
STAT3 Transcription Factor*/metabolism
Humans ; Endothelial Cells/metabolism ; Osteogenesis
Czasopismo naukowe
Tytuł:
Specific Targeting of STAT3 in B Cells Suppresses Progression of B Cell Lymphoma.
Autorzy:
Wang L; Division of Immunotherapy, The Hiram C. Polk, Jr. MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.; School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou 310030, China.
Zhou M; Division of Immunotherapy, The Hiram C. Polk, Jr. MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.; Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Kong X; Division of Immunotherapy, The Hiram C. Polk, Jr. MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.; Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Wu S; Division of Immunotherapy, The Hiram C. Polk, Jr. MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Ding C; Division of Immunotherapy, The Hiram C. Polk, Jr. MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Hu X; Division of Immunotherapy, The Hiram C. Polk, Jr. MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Guo H; Department of Radiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Yan J; Division of Immunotherapy, The Hiram C. Polk, Jr. MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 04; Vol. 24 (17). Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, B-Cell*/genetics
Lymphoma, B-Cell*/therapy
STAT3 Transcription Factor*/genetics
Animals ; Mice ; Adaptor Proteins, Signal Transducing ; Antibodies ; B-Lymphocytes ; RNA, Small Interfering/genetics
Czasopismo naukowe
Tytuł:
Regulatory T cells promote functional recovery after spinal cord injury by alleviating microglia inflammation via STAT3 inhibition.
Autorzy:
Liu R; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Li Y; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Wang Z; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Chen P; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Xie Y; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Qu W; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan, China.
Wang M; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan, China.
Yu Z; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan, China.
Luo X; Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Aug; Vol. 29 (8), pp. 2129-2144. Date of Electronic Publication: 2023 Mar 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Spinal Cord Injuries*
T-Lymphocytes, Regulatory*
STAT3 Transcription Factor*/metabolism
Animals ; Mice ; Axons ; Cytokines ; Inflammation ; Microglia ; Nerve Regeneration ; Recovery of Function ; Spinal Cord
Czasopismo naukowe
Tytuł:
Synthesis and Biological Evaluation of Novel 2-Amino-1,4-Naphthoquinone Amide-Oxime Derivatives as Potent IDO1/STAT3 Dual Inhibitors with Prospective Antitumor Effects.
Autorzy:
Huang RZ; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541199, China.
Liang QL; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541199, China.
Jing XT; State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences of Guangxi Normal University, Guilin 541004, China.; Department of Chemistry & Pharmaceutical Science, Guilin Normal College, Xinyi Road 15, Guilin 541001, China.
Wang K; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541199, China.
Zhang HY; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541199, China.
Wang HS; State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences of Guangxi Normal University, Guilin 541004, China.
Ma XL; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541199, China.
Wei JH; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541199, China.
Zhang Y; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541199, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Aug 19; Vol. 28 (16). Date of Electronic Publication: 2023 Aug 19.
Typ publikacji:
Journal Article
MeSH Terms:
STAT3 Transcription Factor*
Naphthoquinones*/pharmacology
Humans ; Animals ; Mice ; Molecular Docking Simulation ; Prospective Studies ; Amides/pharmacology ; Mice, Inbred BALB C ; Oximes/pharmacology
Czasopismo naukowe
Tytuł:
A novel gain-of-function STAT3 variant in infantile-onset diabetes associated with multiorgan autoimmunity.
Autorzy:
Zhou Q; Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Chen D; Department of Child Healthcare, Lianyungang Maternal and Children's Hospital, Lianyungang, China.
Yu J; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zheng B; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zhou W; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Jia Z; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zhang A; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Gu W; Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2024 Feb; Vol. 12 (2), pp. e2407.
Typ publikacji:
Journal Article
MeSH Terms:
Autoimmunity*/genetics
Diabetes Mellitus*
Female ; Humans ; Gain of Function Mutation ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; Insulin/metabolism
Czasopismo naukowe
Tytuł:
The gp130/STAT3-endoplasmic reticulum stress axis regulates hepatocyte necroptosis in acute liver injury.
Autorzy:
Li X
Wang J
Li Y
He W
Cheng QJ
Liu X
Xu DL
Jiang ZG
Xiao X
He YH; Yi-Huai He, Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, No. 201 Dalian Street, Zunyi, 563000, Guizhou, China, .
Pokaż więcej
Źródło:
Croatian medical journal [Croat Med J] 2023 Jun 30; Vol. 64 (3), pp. 149-163.
Typ publikacji:
Journal Article
MeSH Terms:
STAT3 Transcription Factor*
Necroptosis*
Animals ; Mice ; Cytokine Receptor gp130/genetics ; Hepatocytes ; Endoplasmic Reticulum Stress ; Glycoproteins ; Mice, Inbred BALB C ; Liver
Czasopismo naukowe
Tytuł:
MicroRNA-221-3p inhibits the inflammatory response of keratinocytes by regulating the DYRK1A/STAT3 signaling pathway to promote wound healing in diabetes.
Autorzy:
Hu K; Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.; Department of Endocrinology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Liu L; Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Tang S; Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhang X; Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Chang H; Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Chen W; Central Laboratory, Fujian Medical University Union Hospital, Fuzhou, China.
Fan T; Center of Experimental Practice, Anhui Medical University, Hefei, China.
Zhang L; School of Basic Medical Sciences, Anhui Medical University, Hefei, People's Republic of China.
Shen B; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China. .
Zhang Q; Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Mar 09; Vol. 7 (1), pp. 300. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Diabetic Foot*/genetics
Diabetes Mellitus*/metabolism
Mice ; Animals ; Humans ; Signal Transduction/physiology ; Keratinocytes/metabolism ; Wound Healing/genetics ; Cytokines/metabolism ; Inflammation/genetics ; Inflammation/metabolism ; Glucose/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Tytuł:
Polyphyllin B inhibited STAT3/NCOA4 pathway and restored gut microbiota to ameliorate lung tissue injury in cigarette smoke-induced mice.
Autorzy:
Wang Q; The Affiliated Changsha Central Hospital, Department of Respiratory and Critical Care Medicine, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China.
He Z; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Zhu J; The Affiliated Changsha Central Hospital, Department of Respiratory and Critical Care Medicine, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China.
Hu M; The Affiliated Changsha Central Hospital, Department of Respiratory and Critical Care Medicine, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China.
Yang L; The Affiliated Changsha Central Hospital, Department of Respiratory and Critical Care Medicine, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China.
Yang H; The Affiliated Changsha Central Hospital, Department of Respiratory and Critical Care Medicine, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China. .
Pokaż więcej
Źródło:
BMC biotechnology [BMC Biotechnol] 2024 Mar 08; Vol. 24 (1), pp. 13. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Cigarette Smoking*/adverse effects
Gastrointestinal Microbiome*
Lung Injury*/complications
Lung Injury*/metabolism
Lung Injury*/pathology
Pulmonary Disease, Chronic Obstructive*/therapy
Pulmonary Disease, Chronic Obstructive*/drug therapy
Animals ; Mice ; Cell Line ; Ferritins/metabolism ; Inflammation/pathology ; Lipopolysaccharides/adverse effects ; Lung ; Molecular Docking Simulation ; Nicotiana ; RNA, Ribosomal, 16S ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Tytuł:
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Autorzy:
Pennel KAF; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK. .
Hatthakarnkul P; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Wood CS; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Lian GY; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Al-Badran SSF; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Quinn JA; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Legrini A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Inthagard J; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Alexander PG; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
van Wyk H; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Kurniawan A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Hashmi U; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; University of Glasgow Medical School, Glasgow, G12 8QQ, UK.
Gillespie MA; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Mills M; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Ammar A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Hay J; Glasgow Tissue Research Facility, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Andersen D; Bioclavis Ltd, Glasgow, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Nixon C; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Rebus S; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Chang DK; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Kelly C; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK.
Harkin A; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK.
Graham J; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK.
Church D; Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Tomlinson I; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK.
Saunders M; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
Iveson T; Southampton University Hospital NHS Foundation Trust, Southampton, SO16 6YD, UK.
Lannagan TRM; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Jackstadt R; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Maka N; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Horgan PG; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Roxburgh CSD; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Sansom OJ; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
McMillan DC; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Steele CW; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Jamieson NB; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Park JH; Department of Surgery, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Roseweir AK; University of Glasgow Medical School, Glasgow, G12 8QQ, UK.
Edwards J; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 01; Vol. 43 (1), pp. 64. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Humans ; Animals ; Mice ; Retrospective Studies ; Signal Transduction ; Hypoxia ; Keratins/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
The Phytochemical Agathisflavone Modulates miR146a and miR155 in Activated Microglia Involving STAT3 Signaling.
Autorzy:
Dos Santos BL; Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.; College of Nursing, Federal University of Vale do São Francisco, Av. José de Sá Maniçoba, S/N, Petrolina 56304-917, PE, Brazil.
Dos Santos CC; Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.
da Silva KC; Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.
Nonaka CKV; Center of Biotechnology and Cell Therapy, São Rafael Hospital, D'Or Institute for Research and Teaching (IDOR), Salvador 41253-190, BA, Brazil.
Souza BSF; Center of Biotechnology and Cell Therapy, São Rafael Hospital, D'Or Institute for Research and Teaching (IDOR), Salvador 41253-190, BA, Brazil.; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador 40296-710, BA, Brazil.
David JM; Department of General and Inorganic Chemistry, Institute of Chemistry, Federal University of Bahia, Salvador 40231-300, BA, Brazil.
de Oliveira JVR; Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.
Costa MFD; Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.; National Institute of Translational Neuroscience (INNT), Rio de Janeiro 21941-971, RJ, Brazil.
Butt AM; School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK.
da Silva VDA; Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.
Costa SL; Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.; National Institute of Translational Neuroscience (INNT), Rio de Janeiro 21941-971, RJ, Brazil.; Instituto de Ciências da Saúde, Av. Reitor Miguel Calmon S/N Vale do Canela, Salvador 40110-902, BA, Brazil.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 22; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Biflavonoids*/pharmacology
Alzheimer Disease*/metabolism
MicroRNAs*/genetics
Humans ; Microglia/metabolism ; Interleukin-6/metabolism ; Lipopolysaccharides/pharmacology ; Amyloid beta-Peptides/metabolism ; Cytokines/metabolism ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Tytuł:
Crosstalk between KDEL receptor and EGF receptor mediates cell proliferation and migration via STAT3 signaling.
Autorzy:
Jia J; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.
Zhu L; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.
Yue X; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.
Tang S; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.
Jing S; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.; Present address: Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Tan C; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.
Du Y; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.
Gao J; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China.
Lee I; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China. .
Qian Y; School of Life Science and Technology, ShanghaiTech University, Pudong, Shanghai, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Feb 20; Vol. 22 (1), pp. 140. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Signal Transduction*
ErbB Receptors*/metabolism
Receptors, Peptide*
Humans ; Ligands ; Molecular Chaperones/metabolism ; Cell Proliferation ; Tyrosine ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Tytuł:
Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells.
Autorzy:
Jougasaki M; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Takenoshita Y; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Umebashi K; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Yamamoto M; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Sudou K; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Nakashima H; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Sonoda M; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Kinjo T; Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 13; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Interleukin-6*/metabolism
Myxoma*/metabolism
Humans ; Cells, Cultured ; Proto-Oncogene Proteins c-akt/metabolism ; Receptors, Interleukin-6/metabolism ; Signal Transduction ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Tytuł:
Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers.
Autorzy:
Bose M; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, 28223, USA. .
Sanders A; Department of Bioinformatics, UNC Charlotte, Charlotte, NC, 28223, USA.
Handa A; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, 28223, USA.
Vora A; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, 28223, USA.
Cardona MR; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, 28223, USA.
Brouwer C; Department of Bioinformatics, UNC Charlotte, Charlotte, NC, 28223, USA.
Mukherjee P; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, 28223, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 07; Vol. 14 (1), pp. 3178. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/metabolism
Benzofurans*/pharmacology
Naphthoquinones*/pharmacology
Naphthoquinones*/therapeutic use
Humans ; STAT3 Transcription Factor/metabolism ; Cell Line, Tumor ; Mucin-1/genetics ; Mucin-1/metabolism
Czasopismo naukowe
Tytuł:
ARID5B-mediated LINC01128 epigenetically activated pyroptosis and apoptosis by promoting the formation of the BTF3/STAT3 complex in β2GPI/anti-β2GPI-treated monocytes.
Autorzy:
Tan Y; Institute of Medical Technology, Peking University Health Science Center, Beijing, China.; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Qiao J; Institute of Medical Technology, Peking University Health Science Center, Beijing, China.; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Yang S; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Wang Q; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Liu H; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Liu Q; Institute of Medical Technology, Peking University Health Science Center, Beijing, China.; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Feng W; Institute of Medical Technology, Peking University Health Science Center, Beijing, China.; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Yang B; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Li Z; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Cui L; Institute of Medical Technology, Peking University Health Science Center, Beijing, China.; Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.; Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1539.
Typ publikacji:
Journal Article
MeSH Terms:
Antiphospholipid Syndrome*/genetics
DNA-Binding Proteins*/genetics
DNA-Binding Proteins*/metabolism
Pyroptosis*/genetics
Transcription Factors*/genetics
Transcription Factors*/metabolism
RNA, Long Noncoding*/genetics
Animals ; Humans ; Mice ; Chromatin/genetics ; Chromatin/metabolism ; Monocytes/metabolism ; RNA/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies